跳至主要内容
临床试验/NCT04715139
NCT04715139招募中不适用

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of the Foot and Ankle Products

Arthrex, Inc.7 个研究点 分布在 3 个国家目标入组 700 人开始时间: 2020年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Arthrex, Inc.
入组人数
700
试验地点
7
主要终点
To assess change in Visual Analogue Scale (VAS) survey

研究概览

简要总结

The objective of the registry is to evaluate the continued safety and performance of Arthrex foot and ankle products, including the ProStop® implant for hyperpronated foot; Bio-Compression Screw for reconstruction surgeries of the foot; TRIM-IT Drill Pin® system and/or TRIM-IT Spin Pin™ system for fixation of fractures and fusion (bunionectomy osteotomies) of the foot/ankle; Headless Compression Screws and Compression FT Screws for fixation of small bone fragments of the foot/ankle; DynaNite® nitinol staple for midfoot and hindfoot arthrodeses or osteotomies, first metatarsophalangeal arthrodesis, and mono or bi-cortical osteotomies in the forefoot; BioComposite SutureTak® anchor for medial ankle stabilization; Beveled FT Screws for hallux valgus repair; KreuLock™ screws for ankle fractures; ArthroFLEX® dermal allograft for hallux rigidus arthroplasty; and DualCompression Hindfoot Nail for tibiotalocalcaneal arthrodesis.

详细描述

Device-related adverse events will be continuously assessed and summarized at three months, six months, one year, and two years postoperatively to evaluate safety. A physical exam of the target area will be conducted three months postoperatively to evaluate performance. Range of motion (ROM) will be assessed preoperatively, at three months, six months, and one year postoperatively for the ArthroFLEX® dermal allograft only. Patient-reported outcomes (PROs) will be evaluated for all products at three months, six months, and one year. Additionally, PROs will be assessed at two years postoperatively for ArthroFLEX® dermal allograft and DualCompression Hindfoot Nail only. PROs include the Foot and Ankle Ability Measures (FAAM), Visual Analogue Scale (VAS), Single Assessment Numeric Evaluation (SANE) score, and Veterans Rand 12-Item Health Survey (VR-12). DualCompression X-rays will be evaluated at six months and one year postoperatively for ArthroFLEX® dermal allograft and DualCompression Hindfoot Nail only, and CT scans will be assessed at three months postoperatively for DualCompression Hindfoot Nail only.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject requires surgery using Arthrex foot and ankle products included in the registry.
  • Subject is 18 years of age or over (all products except ProStop®).
  • Subject age >two to 17 years (ProStop® product only).
  • Capable of completing self-administered questionnaires.
  • Willing and able to return for all study-related follow-up visits.
  • Subject or subject's representative signed informed consent and assent, when applicable, and is willing and able to comply with all study requirements.
  • (ArthroFLEX® subjects only):
  • Degenerative or post-traumatic arthritis of the 1st MTP joint with grade 2, 3, or
  • Subjects who require surgical intervention or are medically indicated for an arthrodesis or arthroplasty of the 1st MTP.
  • DualCompression Hindfoot Nail subjects only:
  • The participant must have instability, arthritis, rigid deformity, or severe foot or ankle deformity necessitating tibiotalocalcaneal arthrodesis, commonly referred to as TTC arthrodesis.
  • The participant should be undergoing treatment with the Arthrex DualCompression Hindfoot Nail, either as a primary procedure or as a revision surgery, per standard of care

排除标准

  • Insufficient quantity or quality of bone.
  • Blood supply limitations and previous infections, which may retard healing.
  • Foreign-body sensitivity.
  • Any active infection or blood supply limitations.
  • Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
  • Subjects that are skeletally immature (except for ProStop®).
  • Subject is considered from vulnerable population (i.e., child, prisoner, pregnant).
  • Subjects who are contraindicated for these devices.
  • Subject is currently receiving compensation or benefits due to a work-related injury or illness under any applicable occupational injury or disability program.
  • Subject has a planned or scheduled additional surgery on the affected or contralateral lower extremity within the course of the study.
  • (® Nitinol Staple Subjects only):
  • Subjects who have a comminuted bone surface that would not allow for staple placement as required by the DynaNite® Nitinol Staples directions for use.
  • Subjects who have pathologic bone conditions such as osteopenia that would impair the ability to securely fix the implant as required by the DynaNite® Nitinol Staples directions for use.
  • (ArthroFLEX® subjects only):
  • Additional ipsilateral lower limb pathology that requires active treatment.
  • Bilateral degenerative or post-traumatic arthritis of the 1st MTP joints that would require simultaneous treatment of both MTP joints.
  • Diagnosis of gout.
  • Any significant bone loss, avascular necrosis, and/or large osteochondral cyst (>1cm) of the 1st MTP joint.
  • Lesions greater than 10mm in size.
  • Hallux varus to any degree, or hallux valgus >20 degrees.
  • (DualCompression Hindfoot Nail subjects only):
  • Requiring only a tibiotalar or subtalar arthrodesis
  • Patient requires bulk allograft or metal spacer implant to fill large bony defect and aid in limb salvage

研究组 & 干预措施

All Products listed in Descriptions

  • ProStop
  • BioCompression Screw
  • TRIM-IT Drill Pin/TRIM-IT Spin Pin
  • Headless Compression Screw/Compression FT Screw
  • DynaNite Nitinol Staple
  • BioComposite SutureTak Anchor
  • Beveled Headed FT Screw
  • KreuLock Screws
  • ArthroFLEX dermal allograft
  • DualCompression Hindfoot Nail

干预措施: Products listed in Group/Cohort Description (Device)

结局指标

主要结局

To assess change in Visual Analogue Scale (VAS) survey

时间窗: preoperatively, 3 months, 6 months and 12 months post operative

Patient reported pain scale 0-10 point scale (0 min, 10 max)

To assess changes in Veterans RAND Health (VR-12) survey

时间窗: preoperatively, 3 months, 6 months and 12 months post operative

Patient reported changes in general health and mental survey. Average score is 50 (negative answers bring scores down, positive answers bring score up)

To assess changes in Foot and Ankle Ability Measures (FAAM) survey

时间窗: preoperatively, 3 months, 6 months and 12 months post operative

Patient reported change to physical function for individuals with foot and ankle related impairments. A higher score represents a higher level of physical function

To assess change in Single Assessment Numeric Evaluation (SANE) survey

时间窗: preoperatively, 3 months, 6 months and 12 months post operative

Patient reported change to affected body part on a scale from 0 to 100, with 100 representing their normal function.

次要结局

未报告次要终点

研究者

发起方
Arthrex, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Evaluate the Continued Safety and Performance of the... | 临床试验